200 related articles for article (PubMed ID: 7923555)
1. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target.
Scambia G; Ranelletti FO; Panici PB; De Vincenzo R; Bonanno G; Ferrandina G; Piantelli M; Bussa S; Rumi C; Cianfriglia M
Cancer Chemother Pharmacol; 1994; 34(6):459-64. PubMed ID: 7923555
[TBL] [Abstract][Full Text] [Related]
2. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.
Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y
Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
[TBL] [Abstract][Full Text] [Related]
4. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism.
Critchfield JW; Welsh CJ; Phang JM; Yeh GC
Biochem Pharmacol; 1994 Oct; 48(7):1437-45. PubMed ID: 7945444
[TBL] [Abstract][Full Text] [Related]
5. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
6. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z
Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
[TBL] [Abstract][Full Text] [Related]
7. Paris saponin VII reverses chemoresistance in breast MCF-7/ADR cells.
Li Y; Sun Y; Tang T; Niu Y; Li X; Xie M; Jin H; Mei Q
J Ethnopharmacol; 2019 Mar; 232():47-54. PubMed ID: 30552993
[TBL] [Abstract][Full Text] [Related]
8. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
[TBL] [Abstract][Full Text] [Related]
9. The effects of cyclosporin A, tamoxifen, and medroxyprogesterone acetate on the enhancement of adriamycin cytotoxicity in primary cultures of human breast epithelial cells.
Claudio JA; Emerman JT
Breast Cancer Res Treat; 1996; 41(2):111-22. PubMed ID: 8944329
[TBL] [Abstract][Full Text] [Related]
10. Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer.
Lv L; Liu C; Chen C; Yu X; Chen G; Shi Y; Qin F; Ou J; Qiu K; Li G
Oncotarget; 2016 May; 7(22):32184-99. PubMed ID: 27058756
[TBL] [Abstract][Full Text] [Related]
11. Study of tea polyphenol as a reversal agent for carcinoma cell lines' multidrug resistance (study of TP as a MDR reversal agent).
Zhu A; Wang X; Guo Z
Nucl Med Biol; 2001 Aug; 28(6):735-40. PubMed ID: 11518657
[TBL] [Abstract][Full Text] [Related]
12. Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites.
Scambia G; Ranelletti FO; Benedetti Panici P; Piantelli M; Bonanno G; De Vincenzo R; Ferrandina G; Pierelli L; Capelli A; Mancuso S
Cancer Chemother Pharmacol; 1991; 28(4):255-8. PubMed ID: 1879042
[TBL] [Abstract][Full Text] [Related]
13. Activity of N-benzyl-adriamycin-14-valerate (AD198), a new anthracycline derivate, in multidrug resistant human ovarian and breast carcinoma cell lines.
Harstrick A; Vanhoefer U; Schleucher N; Schroeder J; Baumgart J; Scheulen ME; Wilke H; Seeber S
Anticancer Drugs; 1995 Oct; 6(5):681-5. PubMed ID: 8845478
[TBL] [Abstract][Full Text] [Related]
14. Transfer of p14ARF gene in drug-resistant human breast cancer MCF-7/Adr cells inhibits proliferation and reduces doxorubicin resistance.
Guo-Chang F; Chu-Tse W
Cancer Lett; 2000 Oct; 158(2):203-10. PubMed ID: 10960771
[TBL] [Abstract][Full Text] [Related]
15. Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein.
Chen YN; Mickley LA; Schwartz AM; Acton EM; Hwang JL; Fojo AT
J Biol Chem; 1990 Jun; 265(17):10073-80. PubMed ID: 1972154
[TBL] [Abstract][Full Text] [Related]
16. Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole.
Ishikawa M; Fujita R; Takayanagi M; Takayanagi Y; Sasaki K
Biol Pharm Bull; 2000 Jan; 23(1):112-5. PubMed ID: 10706423
[TBL] [Abstract][Full Text] [Related]
17. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
18. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.
Fogler WE; Pearson JW; Volker K; Ariyoshi K; Watabe H; Riggs CW; Wiltrout RH; Longo DL
J Natl Cancer Inst; 1995 Jan; 87(2):94-104. PubMed ID: 7707396
[TBL] [Abstract][Full Text] [Related]
19. [Effect of different heating methods combined with neferine on the expressions of γH2AX and mdr-1/P-gp in MCF-7/Adr breast cancer cells].
Huang C; Cao P; Xie Z; Zhu H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 36(4):317-22. PubMed ID: 21566283
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of doxorubicin activity in multidrug-resistant cells by mefloquine.
Fujita R; Ishikawa M; Takayanagi M; Takayanagi Y; Sasaki K
Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):281-4. PubMed ID: 11031728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
